×
ADVERTISEMENT

MASH

Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

The FDA has approved semaglutide in conjunction with diet and exercise for the treatment of MASH with moderate to ...

AUGUST 20, 2025

New Trials Suggest Promising Treatment Pipeline for MASH and MASLD

The results of several studies presented at The Liver Meeting 2024 suggest there is a robust treatment pipeline for ...

MAY 23, 2025

Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial

Patients taking the glucagon/glucagon-like peptide-1 receptor dual agonist survodutide saw an 83% improvement in ...

AUGUST 9, 2024

FDA Approves Resmetirom, First Drug for MASH

The FDA granted accelerated approval to the first medication for the treatment of MASH, Rezdiffra.

MARCH 16, 2024

Despite Some Setbacks, Strong Specialty Pipeline Seen in 2024

2023 was a record year for new drug approvals, and while 2024 will probably not exceed that record, specialty ...

FEBRUARY 15, 2024

Pegozafermin Shows Promise for Treating MASH

The new drug pegozafermin could offer a promising treatment for patients with metabolic ...

DECEMBER 15, 2023

NASH: An Interesting Space to Watch

Dr. Aimee Tharaldson, a keynote speaker at AMCP Nexus 2023, spoke with us about the pipeline for nonalcoholic ...

OCTOBER 20, 2023

Load more